176.967 articles found

The redox paradox in neurological disorders: balancing cytoprotection, ferroptosis, and therapeutic targeting.

Premchandani T, Qutub M, Thave T, Taksande J, Tatode A, Umekar M.

Brain Res · 2026-09-05

DOI: 10.1016/j.brainres.2026.150528PMID: 42700879

Functional network reorganization after magnetic resonance-guided focused ultrasound thalamotomy in tremor-dominant Parkinson's disease patients.

Liu J, Purrer V, Krauss J, Borger V, Essler M, Radbruch A, Wüllner U, Upadhyay N, Boecker H.

Neuroimage Clin · 2026-09-05

DOI: 10.1016/j.nicl.2026.104058PMID: 42710366

Hydroxytyrosol as a Multitarget Neuroprotective Agent: Molecular Mechanisms, Pharmacokinetics and Therapeutic Potential in Neurodegenerative Diseases.

Ballester-Navarro P, García-Muñoz AM, Victoria-Montesinos D, Zafrilla P.

Molecules · 2026-09-05

DOI: 10.3390/molecules31173113PMID: 42738773

From Striatum to Prescription: An Evidence-Based and Bayesian Framework for Neuromotor Rehabilitation in Parkinson's Disease.

Rossi A, Ginanneschi F.

NeuroSci · 2026-09-05

DOI: 10.3390/neurosci7050101PMID: 42776673

10d, a Pyridoquinoxaline-Based P-Glycoprotein Inhibitor, Exacerbates MPTP-Induced Neurotoxicity in PC12 Cells.

Cannas C, Rocchitta G, Carta A, Piras S, Migheli R.

Curr Issues Mol Biol · 2026-09-05

DOI: 10.3390/cimb48090912PMID: 42793268

Allele-specific expression modulates the immunological and cis-regulatory landscape of Parkinson's Disease.

Piergiorge RM, Silva ATD, Francisco R, Vasconcelos ATR, Santos-Rebouças CB.

Comput Biol Med · 2026-09-05

DOI: 10.1016/j.compbiomed.2026.111920PMID: 42700515

c-Cbl overexpression alleviates pathological damage in Parkinson's disease by suppressing NLRP3 inflammasome-mediated neuroinflammation via the NF-κB signaling pathway.

Bai C, Qi X, Zhu A, Wang A, Zhu Q, Wang C, Liu G, Liu C, Guo Y.

Biochim Biophys Acta Mol Basis Dis · 2026-09-05

DOI: 10.1016/j.bbadis.2026.168450PMID: 42700873

A Cerebellar Radiomics Model Based on Automatic Segmentation and SHAP-Interpretable Machine Learning for Parkinson's Disease Discrimination

Chen Y, Wang W, Lin A, Qi C, Yang D, Ding L, Wang L.

· 2026-09-04

DOI: 10.21203/rs.3.rs-10589058/v1

LRRK2 variant spectrum and association study in a multi-ethnic cohort of Malaysian Parkinson’s disease patients

Lim KS, Lim JL, Periñan MT, Tay YW, Toh TS, Lit L, Anuar ANK, Ding HX, Ibrahim KA, Mawardi AS, Chia YK, Ooi JCE, Lim TT, Looi I, Schee JP, Beh YY, Cheah WK, Law WC, Wong SC, Ong TL, Chin ML, Teh PC, Lau YH, Lee CLL, Screven L, Bandres-Ciga S, Lim S, Tan AH, Ahmad-Annuar A.

· 2026-09-04

DOI: 10.21203/rs.3.rs-9924440/v1

Are Autistic Traits Elevated and Linked to Functional Outcomes Among People with Parkinson’s Disease?

Spransy R, McQuaid G, Wallace G.

· 2026-09-04

DOI: 10.31234/osf.io/sk8tu_v1

Frontal stimulation reshapes SCAN connectivity and improves motor function in Parkinson’s disease

Panda R, Brissenden JA, Scerbak T, Proctor E, Li Y, Vesia M, Albin RL, Lee TG.

· 2026-09-04

DOI: 10.64898/2026.08.31.748359

Allied health use among women with incident Parkinson’s disease: Population-based findings from the Australian Longitudinal Study on Women’s Health

Paul S, Wong C, Allen N, Dennis S, Cavenagh D, Dolja-Gore X.

International journal of population data science · 2026-09-04